Companies House true 2024-12-01 2025-11-30 false 13012194 uk-bus:Director1 2024-12-01 2025-11-30 13012194 uk-bus:Director2 2024-12-01 2025-11-30 13012194 2024-12-01 2025-11-30 13012194 2025-11-30 13012194 uk-bus:EntityHasNeverTraded 2024-12-01 2025-11-30 13012194 uk-bus:FRS102 2024-12-01 2025-11-30 13012194 uk-bus:FullAccounts 2024-12-01 2025-11-30 13012194 uk-bus:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 13012194 2024-11-30 13012194 uk-bus:OrdinaryShareClass1 2024-12-01 2025-11-30 13012194 uk-bus:OrdinaryShareClass2 2024-12-01 2025-11-30 13012194 uk-bus:OrdinaryShareClass3 2024-12-01 2025-11-30 13012194 uk-bus:PreferenceShareClass1 2024-12-01 2025-11-30 13012194 uk-bus:PreferenceShareClass2 2024-12-01 2025-11-30 13012194 uk-bus:PreferenceShareClass3 2024-12-01 2025-11-30 13012194 uk-core:ShareCapitalPreferenceShares 2025-11-30 13012194 uk-core:ShareCapitalPreferenceShares 2024-11-30 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 13012194

UK BOOSTE BIOENGINEERING CO., LTD

Dormant Accounts

30 November 2025

## UK BOOSTE BIOENGINEERING CO., LTD Registered Number 13012194

## Balance Sheet as at 30 November 2025

|  | 2025 | 2024
--- | --- | --- | ---
|  | £ | £
Called up share capital not paid |  | 10000 | 10000
Net assets |  | 10000 | 10000
Issued share capital
10000 Ordinary Shares of £ 1 each |  | 10000 | 10000
Total Shareholder funds |  | 10000 | 10000

### STATEMENTS

1. For the year ending 30 November 2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 30 November 2025

And signed on their behalf by:
Qiqing TAN, Director